CUSIP 462260100COMIOVAQ4 2025
46 filings · latest Feb 9, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 29.52M | $80.58M |
| 2 | Mhr Fund Management LLC | 28.97M | $79.08M |
| 3 | Vanguard Group Inc | 27.21M | $74.28M |
| 4 | State Street Corp | 20.16M | $55.04M |
| 5 | Bank Of America Corp /De/ | 14.28M | $38.98M |
| 6 | Invenomic Capital Management LP | 11.96M | $32.65M |
| 7 | Morgan Stanley | 9.19M | $25.09M |
| 8 | Goldman Sachs Group Inc | 8.61M | $23.50M |
| 9 |
| 4 | May 15, 2025 | Perceptive Advisors LLC | 13G/A | 3.8% | 12.81M | SEC |
| 5 | Feb 14, 2025 | Perceptive Advisors LLC | 13G/A | 7.3% | 22.11M | SEC |
| 6 | Nov 14, 2024 | Perceptive Advisors LLC | 13G/A | 8.8% | 26.62M | SEC |
| 7 | Oct 18, 2024 | State Street Corp | 13G/A | 4.4% | 13.20M | SEC |
| 8 | Mar 19, 2024 | Quogue Capital LLC | 13D/A | 11.6% | 30.00M | SEC |
| 9 | Mar 1, 2024 | Perceptive Advisors LLC | 13G | 6.9% | 19.22M | SEC |
| 10 | Feb 14, 2024 | Perceptive Advisors LLC | 13G/A | 4.7% | 11.98M | SEC |
See the full Schedule 13D/13G history for Iovance Biotherapeutics Inc.
Unlock full history| 8.60M |
| $23.48M |
| 10 | Geode Capital Management, LLC | 7.99M | $21.82M |